BAG2, MAD2L1, and MDK are cancer-driver genes and candidate targets for novel therapies in malignant pleural mesotheliomaLuisa Bisceglia(University of Pisa), Stefano Landi(University of Pisa)Cancer Gene TherapySeptember 12, 202410.1038/s41417-024-00805-4Cited by 2SaveCiteExport RISWatch citationsRelated PapersDrug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma|Investigational New Drugs|2020|12